How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

The New York Times - Business:

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times - Business. Read the original article.